Compare AbbVie Inc (ABBV) vs SMX Security Matters plc (SMX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbbVie Inc vs SMX Security Matters plc — how do they compare? AbbVie Inc trades at $253.2 (market cap $449.91B), while SMX Security Matters plc trades at $14.56 (market cap $15.08M). The key difference: AbbVie Inc is far larger — about 29834.9× SMX Security Matters plc's market cap, and AbbVie Inc pays a 2.72% dividend while SMX Security Matters plc pays none. Which is the better fit depends on your goals.
| ABBV | SMX | |
|---|---|---|
Market Cap | $449.91B | $15.08M |
Sector | Health | Technology |
52-Week High | $261.07 | $569.32K |
52-Week Low | $184.85 | $12.87 |
Enterprise Value | $513.38B | $12.05M |
Dividend Yield | 2.72% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbbVie (ABBV) trades at $254.44, showing slight daily weakness but maintaining a bullish technical structure with strong institutional support. The company has consistently beaten earnings expectations in recent quarters, with Q1 2026 EPS of $2.65 exceeding the $2.59 estimate. Revenue growth is accelerating, reaching $61.16B in 2025, while the immunology portfolio (Skyrizi, Rinvoq) successfully offsets Humira declines. Analyst consensus remains strongly positive with 68% buy ratings and a $266.33 price target.
The outlook is constructive with robust pipeline developments and dividend growth, though elevated valuation multiples (P/E 124.83, P/B 245.29) and looming patent cliffs in the 2030s present risks. Net income margin compression from 20.38% in 2022 to 6.9% in 2025 requires monitoring, but strong cash generation ($19.03B operating cash flow) supports continued shareholder returns.
SMX (Security Matters PLC) trades at $16.955, up 12.66% today, following two reverse stock splits in May and June 2026. The technical outlook is neutral with mixed moving averages and oscillators, while fundamentals show a P/B of 1.84 but negative ROE and ROA. Recent news highlights the company's focus on recycled plastic traceability and regulatory tailwinds from state recycling mandates.
Outlook is speculative given negative profitability and recent corporate actions. Investment opportunity hinges on adoption of its Circularity-as-a-Service platform, but risks include execution challenges and intense competition in sustainability tech. Wall Street sentiment appears cautious pending evidence of revenue growth and margin improvement.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About SMX Security Matters plc
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →
